TickerFacts.

InMode Ltd. (INMD): Revenue

Annual figures by period end, from SEC filings.

$370.50M
Year ended 2025-12-31
-6.6%
3-year compound annual growth
+12.4%
5-year compound annual growth
$492.05M2017-12-31: $53.46M2018-12-31: $100.16M2019-12-31: $156.36M2020-12-31: $206.11M2021-12-31: $357.56M2022-12-31: $454.27M2023-12-31: $492.05M2024-12-31: $394.82M2025-12-31: $370.50M$370.50M
2017-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$370.50M-6.2%2026-02-10, From 2025-01-01
2024-12-31$394.82M-19.8%2026-02-10, From 2024-01-01
2023-12-31$492.05M+8.3%2026-02-10, From 2023-01-01
2022-12-31$454.27M+27.0%2025-02-04, From 2022-01-01
2021-12-31$357.56M+73.5%2024-02-13, From 2021-01-01
2020-12-31$206.11M+31.8%2023-02-14, From 2020-01-01
2019-12-31$156.36M+56.1%2022-02-10, From 2019-01-01
2018-12-31$100.16M+87.4%2021-02-10, From 2018-01-01
2017-12-31$53.46Mn/a2020-02-18, From 2017-01-01

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
InMode Ltd. (INMD)2025-12-31$370.50M-6.2%
TransMedics Group, Inc. (TMDX)2025-12-31$605.49M+37.1%
Axogen, Inc. (AXGN)2025-12-31$225.21M+20.2%
Outset Medical, Inc. (OM)2025-12-31$119.48M+5.1%
Conmed Corp (CNMD)2025-12-31$1.37B+5.2%
LivaNova PLC (LIVN)2025-12-31$1.39B+10.7%
Biolife Solutions Inc (BLFS)2025-12-31$96.21M+28.9%
Vaso Corp (VASO)2025-12-31$89.10M+2.7%
Ceribell, Inc. (CBLL)2025-12-31$89.06M+36.1%

Compare INMD, TMDX, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗